Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Grifols Sa > Profile

Grifols Sa (GRFS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Permian Investment Partners

Alex Duran And Scott Hendrickson

 16,187,321 $120,433,668 +32% 18.73%
2.
Armistice Capital

Steven Boyd

 10,036,000 $74,667,840 +6% 1.01%
3.
Millennium Management

Israel Englander

 9,352,424 $69,582,035 -13% 0.03%
4.
Soleus Capital

Guy Levy

 6,605,425 $49,144,362 +47% 3.08%
5.
Whitebox Advisors

Andy Redleaf

 3,947,631 $29,370,375 -7% 0.84%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1.
Versant Capital Management, Inc
 3,912 $27,814 0%
News See All
12 Best Low Price Pharma Stocks To Invest In Right Now

12 Best Low Price Pharma Stocks To Invest In Right Now

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...

Keep Reading →

February 25th, 2025 - Hedge Funds News

Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript

Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript

Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.

Keep Reading →

May 20th, 2024 - News Transcripts

Grifols, S.A. (NASDAQ:GRFS) Q3 2023 Earnings Call Transcript

Grifols, S.A. (NASDAQ:GRFS) Q3 2023 Earnings Call Transcript

Nuria Pascual: Hello, everyone, and welcome to the Grifols Third Quarter 2023 Conference Call. Thank you very much for taking the time to join us today.

Keep Reading →

November 3rd, 2023 - News Transcripts

Grifols, S.A. (NASDAQ:GRFS) Q2 2023 Earnings Call Transcript

Nuria Pascual: Hello everyone, and welcome to the Grifols' Second Quarter 2023 Conference Call. Thank you very much for taking the time to join us today.

Keep Reading →

July 29th, 2023 - News Transcripts

10 Best Pharma Stocks To Buy Now

10 Best Pharma Stocks To Buy Now

With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.

Keep Reading →

October 24th, 2022 - Hedge Funds News

10 Best Low Price Pharma Stocks To Buy Now

10 Best Low Price Pharma Stocks To Buy Now

The global pharmaceuticals market was forecasted to grow from $1454.66 billion in 2021 to $1587.05 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%.

Keep Reading →

October 18th, 2022 - Hedge Funds News

10 Best Medical Stocks Under $10

10 Best Medical Stocks Under $10

According to the Centers for Medicare and Medicaid Services, U.S spending on national healthcare touched $4.1 trillion in 2020, which amounts to an expenditure of $12,530 per person.

Keep Reading →

August 6th, 2022 - Hedge Funds News

Is GRFS A Good Stock To Buy Now?

Is GRFS A Good Stock To Buy Now?

After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

Keep Reading →

December 16th, 2020 - Hedge Funds News

Is Grifols SA (GRFS) Going to Burn These Hedge Funds?

Is Grifols SA (GRFS) Going to Burn These Hedge Funds?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Keep Reading →

October 7th, 2020 - Hedge Funds News

Did Hedge Funds Make The Right Call On Grifols SA (GRFS) ?

Did Hedge Funds Make The Right Call On Grifols SA (GRFS) ?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

July 17th, 2020 - Hedge Funds News

Click here to See All News
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)